Surgical outcome of metachronous hepatic metastases secondary to gastric cancer.
The prognosis of hepatic metastasis from gastric carcinoma is dismal. A few patients are candidates for hepatic resection. The present study analyzed the oncologic outcomes of hepatic resection performed in metachronous hepatic metastasis from gastric cancer. Between January 1986 and November 2007, 14 patients underwent hepatectomy for metachronous hepatic metastasis secondary to gastric adenocarcinoma. Clinicopathological data were reviewed retrospectively. The median interval between gastrectomy and hepatectomy was 12.9 months. The numbers of hepatic lesions were single in 9 patients, more than two in 5 patients. The overall survival rates following hepatectomy were 67.0% at 1 year, 38.3% at 3 year. The disease progression occurred in 10 patients in the remaining liver. Surgical resection could be a treatment option for the hepatic metastasis from gastric cancer. The comparison of efficacy between surgical resection and the other treatment modalities will be required.